pharma

Antitrust Enforcement Is Not Enough to Address Anticompetitive Conduct in Pharmaceutical Markets. Market-Oriented Legal Reform is Needed.

Federal antitrust enforcement has been robust and effective in promoting prescription drug market competition and thereby enhancing consumer welfare. Antitrust enforcement in...

A New Capitalisn’t Episode: a Coronavirus Reading List

In this episode, Kate and Luigi give an economist's view of the coronavirus outbreak: How should we think about the economic trade-offs of interventionist...

LATEST NEWS

Antitrust and Competition

Startup Acquisitions Have Undecided Effects on Innovation and Economic Growth

Christian Fons-Rosen, Pau Roldan-Blanco, Tom Schmitz

Startups are a major driver of innovation, but many startups are acquired by large incumbents. Do these acquisitions stifle innovation or promote...

ESG & Corporate Governance

History Shows that Voluntary ESG Standards Lead to a More Focused ESG Disclosure

Ethan Rouen, Kunal Sachdeva, Aaron Yoon

In recent years, ESG reports have become more common for publicly traded companies. However, critics have found the information they provide to...

Regulation

Letters that Matter: How Interest Groups Shape Financial Legislation

Renée Adams, Thomas Mosk

Members of Congress are inundated with an avalanche of correspondence on a daily basis. But what persuades them to heed the call?...

Labor

Are There Really Gender Pay Differences in the CEO Labor Market?

Massimiliano Tani, Keiran Sharpe, Andrew Valentine

The gender pay gap is a well-documented phenomenon in global labor markets, but this gap does not seem to apply to the...

Monetary Policy

How Many Banks Are at Risk of Insolvency Right Now?

Amit Seru, Erica Xuewei Jiang, Gregor Matvos, Tomasz Piskorski

Given the recent banking turmoil and failure of SVB and Signature and issues in First Republic, it is important to understand the...